C
ELV icon

Cerebellum’s Elevance Health ELV Stock Holding History

Cerebellum’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$541K Buy
+1,792
New +$493K 0.29% 231

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Cerebellum's ELV Position: Q4 2019 in Review

Cerebellum opened a new position in Elevance Health (ELV) in Q4 2019: 1,792 shares worth $541K. The stake represents 0.29% of the portfolio and ranks #231 among its holdings.

1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Cerebellum held 1,792 shares of Elevance Health worth $541K as of Q4 2019.
  • Elevance Health was a new Cerebellum position in Q4 2019.
  • Elevance Health made up 0.29% of Cerebellum's portfolio in Q4 2019, its #231 holding.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.